Company: CRAC
Filing Date: 2025-07-16
Form Type: S-1/A
Source: 0001213900-25-064764
Chunk: 15

Company: Crown Reserve Acquisition Corp. I
Filing Date: 2025-07-16
Form: S-1/A
Chunk 15
---
 experience of our management team and can benefit from our operational expertise. We will have a generalist approach to industry sectors, but with particular emphasis on industries where we have core competencies and experiences, such as pharma, medical technology and medical equipment, and healthcare IT industries. However, we may pursue an initial business combination opportunity in any industry or sector (subject to certain limitations described in this prospectus). Our Leadership Our management team and board consist of seasoned industry executives that possess deep collective understanding of various industries, including the pharma, medical technology and medical equipment, and healthcare IT, as well as the evolution of these sectors and market opportunities. 2 Management Team Prashant Patel(age: 51) serves as Chairman and Chief Executive Officer. Mr. Patel currently serves on the board of Wellgistics Health, Inc. (f/k/a Danam Health Inc. (NASDAQ:WGRX)) since January 2023. Mr.Patel served as a director and president of TRxADE Health, Inc. (NASDAQ: MEDS) from 2014 to June 2023. Mr.Patel served as a director and president of Sceinture Holdings Inc. (NASDAQ: SCNX) from June 2023 to April 2025. Additionally, Mr. Patel has been a board advisor to several special purpose acquisition companies over the years including Oceantech Acquisitions I Corp, (NASDAQ: OTAC) since March 2023, Aspire Biopharma Inc. (NASDAQ: PWUP) from August 2023 to June 2024, and Aesther Healthcare Acquisition Corp. (n/k/a Ocean Biomedical, Inc. (NASDAQ: OCEA)) from June 2021 until the completion of its initial business combination in February 2023. Mr. Patel is a seasoned entrepreneur and a registered pharmacist with experience in multiple aspects of the pharmaceutical, biotech and healthcare industries. Mr. Patel also founded and operated Tampa Bay Pharmacy and Apaa LLC, community pharmacies, between 2008 and 2014 and Pharmaceutical Returns of America LLC, a Florida based pharmaceutical reverse distributor, between 2006 and 2010. Mr. Patel has also been a consultant to several return logistics pharmaceutical companies over the years. Mr. Patel possesses an excellent vision to bring transparency, efficiency and cost benefits to US pharmaceutical channel partners. After graduating with a BPharm from University of Nottingham/UK, Mr. Patel completed MSC in Transport, Trade & Finance from Cass Business School, City University, UK